PMK 032 Eczema, Psoriasis and Pruritus Treatment
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Scrophularia nodosa Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 400 mg | 40 mg | Not calculated |
| Scrophularia nodosa Source : Fleur Extraction ratio : 10:1 Dry plant equivalent : 400 mg | 40 mg | Not calculated |
| Taraxacum officinale Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 2,000 mg | 200 mg | Not calculated |
Non-medicinal ingredients
Talc, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Dandelion is traditionally used in Herbal Medicine as an alternative to help relieve dermatological conditions such as eczema. Figwort is traditionally used in Herbal Medicine to relieve symptoms of chronic cutaneous diseases eczema, psoriasis and pruritus. Figwort is traditionally used in Herbal Medicine to relieve symptoms of eczema, psoriasis and pruritus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have heart disease.
Product record
- Other names
- Eczema, Psoriasis and Pruritus Treatment, Generic Eczema, Psoriasis and Pruritus Treatment
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80037583
- Status
- Active licence
- Licence date
- 19 November 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80037583
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PMK 032 Eczema, Psoriasis and Pruritus Treatment (PMK Federal Regulatory Consultants Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80037583-pmk-032-eczema-psoriasis-and-pruritus-treatment, updated 19 November 2012.